The document discusses the growing role of digital collaboration in pharmaceutical marketing, particularly in the Asia Pacific region. It notes that physicians' social networks have over 3 million members in Asia Pacific, dominating the global market. The document also explores opportunities for pharmaceutical companies to partner with patients online to gain real-world insights into drug usage and patient experiences. It emphasizes that building trust with physicians, patients and other stakeholders through open and responsive engagement will be crucial for pharmaceutical companies going forward.

1. Collaborative Digital Pharma Marketing A Role Model for Asia Pacific Healthcare? Len Starnes Head of Digital Marketing & Sales General Medicine From Drugs to Brands Singapore 10 March 2011 Len Starnes Bayer Healthcare Pharma

2. Pharma is reinventing itself

3. ‘ We are living in the middle of the largest increase in expressive capability in the history of the human race’ Clay Shirkey, Here Comes Everybody, 2008

4. Collaboration Process where two or more people or organizations work together to realize shared goals Wikipedia

5. The power of digital collaboration

6. Social networking Public relations Consumers & patients Non-traditional HC partners Physicians High-impact zones R&D & Clinical E 2.0

7. Collaborative digital marketing is not for the faint-hearted Warning

8. Physicians

9. Physicians’ social networks Ubiquitous Transformational

10. Transforming the exchange of medical information Pharmaceutical industry Peer-to-peer dialogue Medical profession Collaborative environment

11. Next 5 years Highly e-savvy physicians Routine use of SNs by majority of physicians More physicians willing to engage with pharma on SNs More physicians expecting e-self service from pharma Fewer physicians willing to see sales reps Predominance of multi-channel engagement models

12. 2010 2009 2008 2007 Sustained growth Today > 70 networks > 3m members Membership of physicians’ social networks 1m 2m 3m 2011

13. 2 million members Asia Pacific 1 million members USA & Europe Asia Pacific region dominates

14. Global network exclusively for cardiologists By invitation only Merges NEJM content with community discussion > 3000 members

15. 180k members Pan-European Alliance 2011 Connecting networks in France Italy Germany Spain UK

16. 115,000 members each

17. Manhattan Research, Taking the Pulse Asia v10, 2010 % physician respondents India and China lead on use Physicians’ social networks

18. World’s largest healthcare professionals’ network 1,700,000 members China dxy.cn

19. haoyisheng.com Visited by 79% of physicians using internet for professional reasons

20. m3.com, Japan Authenticated users 177,000 members Visited by 93% of physicians using internet for professional reasons

21. MediGate S Korea Authenticated users 67,000 members Visited by 72% of physicians using internet for professional reasons

22. Australia’s 1st true doctors’ social network Launched September 2010 > 5000 members* Multiple pharma collaboration options * Status 1.3.11 www.e-healthspace.com.au

23. Pharma’s partnering options Observation Treatment trends, unmet needs Engagement Peer-to-peer dialogue Building hybrid models Community, content & services Research Surveys, opinion

24. Build deeper relationships Open peer-to-peer dialogue Long-term opportunities Develop trusted speciality fora Integrate community & resources Reduce reliance on sales forces Increase reach and SOS

25. 39% prefer Unique opportunities to develop authenticated networks 61% indifferent + prefer no login 65% prefer 35 % indifferent + prefer no login Manhattan Research, Taking the Pulse Asia v10, 2010

26. Patients

27. ‘ Let patients help. We are the ultimate motivated stakeholders ’ ePatient Dave US HIT Policy Committee 25 April 2010

28. Palpably visible

29. ‘ If you have not read this white paper you do not understand the future of medicine’ John Sharp Cleveland Clinic

30. Pharma is discovering the benefits of collaborating with eP atients

31. Mellanie True Hills Former atrial fibrillation sufferer 2,200 Twitter followers

32. Linda Lan-yu Sun President Taiwan Breast Cancer Alliance (TBCA) Empowering patients to ‘talk to doctors as equals’

33. http://www.pharmachinaonline.com/Archives/index_1_news.asp?id=435&sortid=28 ‘… patient education (in China)…needs to shift from simply the provision of information to including motivating and transforming a patient’s mindset to assume a proactive role in his or her own health management’ Learning from Taiwan

34. Patients are… sharing quantitative personal health data

35. The data-driven community Patients share structured information about their disease to help themselves and others Quantifiable, measurable, actionable

36. Insights on drug usage in the real world MS treatment: Copaxone 3050 patient community 1073 patient evaluations Status: 14.2.11

37. ‘ In future the less private you are, the longer you’ll live’ Jamie Heywood Co-founder & Chairman PatientsLikeMe

38. Partnerships to capture real-world experiences ‘… may help UCB better understand how patients live with epilepsy and help advance epilepsy care’ Peter Verdu, VP Clinical Research, UCB, 2009

39. Demonstrable high-level vision ‘… will shape the way we do our work, and ultimately help improve transplant patient outcomes now and in the future.’ Joe Jiminez Novartis CEO, 2010

40. What relationship with ePatients should pharma have? What relationship with pharma do ePatients want?

41. PR Image: eDrug Research.com

42. Mistrust between industry and consumers Broken trust between industry and the medical profession Ethos of the industry is constantly called into question

43. Trust is crucial for survival ‘ We need to foster trust between pharma and academic and scientific communities so that we can work together to create the innovative breakthroughs that will fulfil unmet needs and benefit patients everywhere’ Paul Stoffels Head of Global R&D, Johnson & Johnson

44. JnJ is showing how to build trust again

45. Marc Monseau is the human face of JnJ on the internet… … and a social media evangelist

46. Empowered to get JnJ back into ‘ The Conversation’ ‘ Everyone else is talking about our company, so why can’t we?’

47. Empowered to engage in ‘ what’s happening now’ conversations

48. Empowered to engage the blogging health community

49. Empowered to talk frankly about JnJ’s social media journey ‘ Being open, responsive and timely’

50. Pharma will become more